Clinical trials for Waldenström Macroglobulinemia
9 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07471074Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström MacroglobulinemiaCentre Hospitalier Universitaire, Amiens
- RECRUITINGPhase 2NCT06986174A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström MacroglobulinemiaShayna Sarosiek, MD · PI: Shayna Sarosiek, MD
- RECRUITINGPhase 4NCT07169331A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström MacroglobulinemiaBeiGene · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 2NCT05952037A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström MacroglobulinemiaBeOne Medicines · PI: Study Director
- RECRUITINGPhase 2NCT05734495Pirtobrutinib and Venetoclax in Waldenström MacroglobulinemiaDana-Farber Cancer Institute · PI: Jorge Castillo, MD
- RECRUITINGNCT05640102Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström MacroglobulinemiaBeiGene · PI: Study Director
- RECRUITINGN/ANCT04893564Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström MacroglobulinemiaCentre Hospitalier Universitaire, Amiens
- RECRUITINGN/ANCT04898647Clinical Study of the Hyperviscosity Syndrome in Waldenström MacroglobulinemiaCentre Hospitalier Universitaire, Amiens
- ACTIVE NOT RECRUITINGPhase 2NCT02180724An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström MacroglobulinemiaAcerta Pharma BV · PI: AstraZeneca Clinical study Information Center